Advertisement
Screener

LA JOLLA PHARMACEUTICAL CO Interest Expense, Borrowings

LA JOLLA PHARMACEUTICAL CO Interest Expense, Borrowings

LA JOLLA PHARMACEUTICAL CO reported Interest Expense, Borrowings of $2.40 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpenseBorrowings · last filed 2022-08-15

  • LA JOLLA PHARMACEUTICAL CO interest expense, borrowings for the quarter ending 2022-06-30 was $2.40M, a 11.11% decline year-over-year.
  • LA JOLLA PHARMACEUTICAL CO interest expense, borrowings for the quarter ending 2022-03-31 was $2.40M, a 7.69% decline year-over-year.
  • LA JOLLA PHARMACEUTICAL CO interest expense, borrowings for the quarter ending 2021-12-31 was $2.40M, a 7.69% decline year-over-year.
  • LA JOLLA PHARMACEUTICAL CO interest expense, borrowings for the quarter ending 2021-09-30 was $2.70M, a 8.00% increase year-over-year.
  • LA JOLLA PHARMACEUTICAL CO interest expense, borrowings for fiscal 2021 was $10.40M, a 4.00% increase from fiscal 2020.
  • LA JOLLA PHARMACEUTICAL CO interest expense, borrowings for fiscal 2020 was $10.00M, a 7.41% decline from fiscal 2019.
  • LA JOLLA PHARMACEUTICAL CO interest expense, borrowings for fiscal 2019 was $10.80M.
Period endInterest Expense, Borrowings 3 monthInterest Expense, Borrowings 6 monthInterest Expense, Borrowings 9 monthInterest Expense, Borrowings 12 month
2022-06-30$2.40M
10-Q · filed 2022-08-15
$4.80M
10-Q · filed 2022-08-15
$7.20M
derived: sum of 3 quarters · filed 2022-08-15
$9.90M
derived: sum of 4 quarters · filed 2022-08-15
2022-03-31$2.40M
10-Q · filed 2022-05-16
$4.80M
derived: sum of 2 quarters · filed 2022-05-16
$7.50M
derived: sum of 3 quarters · filed 2022-05-16
$10.20M
derived: sum of 4 quarters · filed 2022-08-15
2021-12-31$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09
$5.10M
derived: sum of 2 quarters · filed 2022-03-09
$7.80M
derived: sum of 3 quarters · filed 2022-08-15
$10.40M
10-K · filed 2022-03-09
2021-09-30$2.70M
10-Q · filed 2021-11-04
$5.40M
derived: sum of 2 quarters · filed 2022-08-15
$8.00M
10-Q · filed 2021-11-04
$10.60M
derived: sum of 4 quarters · filed 2022-08-15
2021-06-30$2.70M
10-Q · filed 2022-08-15
$5.30M
10-Q · filed 2022-08-15
$7.90M
derived: sum of 3 quarters · filed 2022-08-15
$10.40M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$2.60M
10-Q · filed 2022-05-16
$5.20M
derived: sum of 2 quarters · filed 2022-05-16
$7.70M
derived: sum of 3 quarters · filed 2022-05-16
$10.20M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09
$5.10M
derived: sum of 2 quarters · filed 2022-03-09
$7.60M
derived: sum of 3 quarters · filed 2022-03-09
$10.00M
10-K · filed 2022-03-09
2020-09-30$2.50M
10-Q · filed 2021-11-04
$5.00M
derived: sum of 2 quarters · filed 2021-11-04
$7.40M
10-Q · filed 2021-11-04
$9.80M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$2.50M
10-Q · filed 2021-08-05
$4.90M
10-Q · filed 2021-08-05
$7.30M
derived: sum of 3 quarters · filed 2021-08-05
$10.10M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$2.40M
10-Q · filed 2021-05-07
$4.80M
derived: sum of 2 quarters · filed 2021-05-07
$7.60M
derived: sum of 3 quarters · filed 2021-05-07
$10.40M
derived: sum of 4 quarters · filed 2021-05-07
2019-12-31$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08
$5.20M
derived: sum of 2 quarters · filed 2021-03-08
$8.00M
derived: sum of 3 quarters · filed 2021-03-08
$10.80M
10-K · filed 2021-03-08
2019-09-30$2.80M
10-Q · filed 2020-11-09
$5.60M
derived: sum of 2 quarters · filed 2020-11-09
$8.40M
10-Q · filed 2020-11-09
2019-06-30$2.80M
10-Q · filed 2020-08-06
$5.50M
10-Q · filed 2020-08-06
2019-03-31$2.70M
10-Q · filed 2020-05-04
2018-09-30$2.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-24
$4.42M
10-Q · filed 2018-10-24
2018-06-30$1.66M
10-Q · filed 2018-08-08
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-24
$0.00
10-Q · filed 2018-10-24
2017-06-30$0.00
10-Q · filed 2018-08-08